This web site is provided to you by Trillium Therapeutics Inc. (“Trillium”). Your use of this web site and any other web sites operated or provided by Trillium or its affiliated or related entities, (collectively, the “Site”) is subject to the following terms and conditions, as may be amended from time to time (the “Terms”). Your use of this Site, or continued use of the Site, constitutes your acceptance of these Terms in current and modified form. If you do not agree to the Terms, you may not use the Site.
Use of the Site
The Site, including any web pages, text, images, sounds, software, and other data or information contained in the Site (the “Data”), are provided for general informational purposes, only for your personal use and is not intended to be used in making any decision relating to an investment in securities of Trillium. You may not use the Site for any purpose that is unlawful under applicable law, or prohibited by these Terms. You may view and print out web pages from the Site for personal use, but may not otherwise copy, modify, or use any of the Data. Except as expressly permitted by Trillium, you may not use the Site or the Data for commercial purposes. You may not remove any copyright or other proprietary notices from copies of the Data. Trillium disclaims any and all liability for consequences which may result from unauthorized reproduction or use of the Data. Nothing on the Site is to be considered an offer by Trillium to accept an investment in the company.
Forward Looking Statements and Accuracy of Data
This Site contains forward-looking statements within the meaning of applicable securities laws. These forward looking statements are not based on historical facts but rather on management’s expectations regarding future activities, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. All statements contained herein that are not clearly historical in nature are forward-looking, and the words “anticipate”, “believe”, “expect”, “estimate”, “may”, “will”, “could”, “leading”, “intend”, “potential”, “contemplate”, “should”, “plan”, “predict” and similar expressions are generally intended to identify forward-looking statements. All forward-looking statements are based on our beliefs and assumptions based on information available at the time the assumption was made. By its nature, forward-looking information involves numerous assumptions, inherent risks and uncertainties, both general and specific, that contribute to the possibility that the predictions, forecasts, projections or other forward-looking statements will not occur. Such forward looking statements reflect current beliefs and assumptions of Trillium’s management and are based on information currently available to management. Forward looking statements involve significant known and unknown risks, uncertainties and assumptions and other factors that may cause Trillium’s actual results, levels of activity, performance or achievements to differ materially from those implied by the forward looking statements. A discussion of risks and uncertainties facing Trillium appears in Trillium’s Annual Information Form for the year ended December 31, 2017 filed with Canadian securities authorities and available at www.sedar.com and on Form 40-F with the U.S. Securities Exchange Commission and available at www.sec.gov, each as updated by Trillium’s continuous disclosure filings, which are available at www.sedar.com and at www.sec.gov. These factors should be considered carefully and prospective investors should not place undue reliance on the forward looking statements. Although the forward looking statements contained on the Site are based upon what management believes to be reasonable assumptions, Trillium cannot assure investors that actual results will be consistent with these forward looking statements. Forward looking statements and other Data are based on information that is no more current than the date the statements or Data are posted on the Site and Trillium assumes no obligation to update or revise the information provided to reflect new events or circumstances, unless required by applicable law. Data contained on the Site is provided on an “as is” basis and is subject to change without notice. The Data may be inaccurate, out-of-date, or otherwise incorrect. Please contact Trillium to obtain current Data.
TRILLIUM THERAPEUTICS INC. PROVIDES THE SITE AND THE DATA ON AN “AS IS” BASIS. TRILLIUM THERAPEUTICS INC. DISCLAIMS ALL REPRESENTATIONS, WARRANTIES AND CONDITIONS, EXPRESS OR IMPLIED, WITH REGARD TO ALL INFORMATION PROVIDED IN AND THROUGH THE SITE INCLUDING, WITHOUT LIMITATION, REPRESENTATIONS, WARRANTIES AND CONDITIONS REGARDING COMPLETENESS, ACCURACY, CURRENCY, SATISFACTORY QUALITY, FITNESS FOR A PARTICULAR PURPOSE, MERCHANTABILITY, NON-INFRINGEMENT, AND TIMELINESS OF ANY PRODUCT OR SERVICE. YOU EXPRESSLY UNDERSTAND AND AGREE THAT TRILLIUM THERAPEUTICS INC. AND ITS AFFILIATED OR RELATED ENTITIES, AND THEIR RESPECTIVE OFFICERS, DIRECTORS, EMPLOYEES, AND AGENTS, SHALL NOT BE RESPONSIBLE OR LIABLE FOR INDIRECT, SPECIAL, THIRD PARTY, CONSEQUENTIAL, INCIDENTAL, PUNITIVE, EXEMPLARY OR OTHER DAMAGES, INCLUDING WITHOUT LIMITATION, DAMAGES FOR LOSS OF USE, DATA, REVENUE, PROFITS, OR OTHER INTANGIBLE LOSSES, RELATED TO, OR ARISING FROM, DIRECTLY OR INDIRECTLY, (1) YOUR USE OR INABILITY TO USE THE SITE; (2) YOUR USE OF OR RELIANCE ON THE INFORMATION CONTAINED IN OR THROUGH THE SITE; OR (3) ANY OTHER MATTER RELATED TO THE SITE.
As a condition of use of the Site, you agree to indemnify and hold Trillium and its affiliated or related entities, and their respective officers, directors, employees and agents, harmless from and against any and all claims against, and any related losses incurred by, Trillium (including without limitation damages, losses, expenses, reasonable legal fees and charges) resulting from or arising out of your use of the Site, including without limitation any claims alleging facts that if true would constitute a breach by you of these Terms.
Links to Third Party Site
The Site may contain links to third party web sites. Because Trillium has no control over such sites, you understand and agree that Trillium is not responsible for the availability of such sites and that Trillium does not endorse and is not responsible or liable for any content, advertising, products, or other materials on or available from such sites or resources (“Third Party Content”). You further acknowledge and agree that Trillium shall not be responsible or liable, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with use of or reliance on any Third Party Content.
By submitting personal information (which means information about an identifiable individual, as defined under applicable Canadian privacy laws), including, without limitation, your contact information (your “Personal Information”) to Trillium, its resellers, agents or affiliates, you agree that any such party may collect, use, and/or disclose your Personal Information for the purposes listed on the Site from time to time and for any purpose otherwise permitted or required by law. You permit Trillium to collect and store your Personal Information in order to provide information you request and to send you information related to Trillium’s business that we feel you might be interested in. Trillium reserves the right to use Personal Information internally, and to share aggregated and anonymized information externally, for statistical or demographic purposes. Trillium takes physical, organizational and technological measures to safeguard your Personal Information against unauthorized access, disclosure, copying, use, or modification. Trillium retains Personal Information for as long as necessary to fulfill the purposes for which it is collected or as required by law. For additional information on how: (i) your Personal Information is collected, used and disclosed by Trillium in connection with your use of the Site; (ii) to access your Personal Information held by Trillium; (iii) to make corrections or deletions in respect of your Personal Information; or (iv) to make a complaint about Trillium’s Personal Information handling practices, please contact our Chief Financial Officer at email@example.com. You agree that we may provide your Personal Information to legal, financial or other professional advisors or in connection with the sale or reorganization of all or part of Trillium’s business or operations. Unless otherwise agreed in writing by Trillium, all information provided by you, including, without limitation, any comments or opinions you may provide to Trillium through the Site, is provided on a non-confidential basis and becomes the exclusive property of Trillium, and you expressly consent to the unrestrained use of all such information by Trillium.
This Site and all intellectual property rights in the Site (including without limitation any Data) are owned by Trillium and/or its suppliers. Trillium and its suppliers reserve all intellectual property rights (including without limitation all copyright, trade-marks, domain names, design rights, database rights, patents and all other intellectual property rights of any kind) whether registered or unregistered anywhere in the world. Nothing in these Terms grants you any rights in the Site other than as necessary to enable you to access the Site. “TRILLIUM THERAPEUTICS INC.”, Trillium’s logo, as displayed on the Site and all other distinguishing words or logos relating to Trillium are trade-marks and/or registered trade-marks of Trillium and may not be used without the prior written consent of Trillium.
Governing Law and Venue
These Terms and your use of the Site shall be governed by and interpreted in accordance with the laws of Ontario, excluding rules of private international law that lead to the application of the laws of any other jurisdiction. The courts of Ontario shall have the non-exclusive jurisdiction to hear any matter arising in connection with these Terms.
These Terms constitute the entire agreement between you and Trillium with respect to the Site, the information contained therein, and any information obtained through the Site by communication with Trillium personnel. If any part of these Terms is unenforceable, the enforceability of any other part of these Terms will not be affected.
Unsolicited Ideas Policy
Trillium depends primarily upon its employees and retained consultants to generate ideas. Because of complex legal issues associated with unsolicited idea submission, involving matters such as intellectual property rights and confidential relationships, it is Trillium’s policy to consider an unsolicited idea only when it is the subject matter of an issued patent or a publicly available patent application. Please do not otherwise submit any unsolicited ideas, suggestions or other works in any form to Trillium, its subsidiaries, or any of its employees and directors. We hope that you appreciate the purpose of this policy is to avoid potential misunderstandings or disputes when Trillium products might seem similar to ideas submitted to Trillium. If despite our request that you do not send us your ideas, you still submit them, then regardless of what your letter says the following terms shall apply to your submissions.
Terms of Unsolicited Idea Submission
You agree that: (1) the unsolicited idea is considered a confidential disclosure of Trillium unless Trillium deems otherwise; (2) the unsolicited idea is deemed to be the exclusive property of Trillium; and (3) Trillium can use the unsolicited idea for any purpose, in any way, and even disclose it to others, and with no obligation to provide you with any compensation and with no other obligations. Trillium shall not be liable, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with use and/or disclosure of any unsolicited ideas.
This Site is intended for and directed to residents of Canada over the age of 18 years. Trillium will not knowingly collect Personal Information about a minor under the age of 18.